Happy Friday, all. In honor of the long holiday weekend, here is an early edition of the Week in Review.

As expected, the week was relatively quiet. The major exception was in the life sciences and biotech industry. Led by Amgen’s $10.4B acquisition of Onyx, there were roughly a dozen deals in the space. In other news, private equity firms may be seeking less traditional LPs for new funds and Potbelly files for IPO of up to $75M.

Investments:

Opinions:


Member Spotlight:

Boyne Capital Partners is a Miami-based private equity firm focused on making control investments in lower middle market companies, in situations with high degree of profitable growth. The firm joined Axial in 2013.

Boyne specializes in providing the capital necessary to fund corporate growth and facilitate shareholders’ exits. Approximately 50% of the firm’s transactions have been recapitalizations of owner operated businesses with the remainder being corporate divestitures from larger corporations, restructurings or special situation opportunities.

Boyne primarily focuses on investments in niche manufacturing, business services, healthcare services, specialty services, value-added distribution, waste management, waste water and related fields, next generation energy, and restaurants.

Connect with Boyne or any of the other 13,000+ Axial Members.